$JAGX 🐆💰 **MULTI-BILLION-DOLLAR POTENTIAL?** 🚀
$JAGX
🧬 MVID NDA targeted Q1 2027
⚡ Potential FDA Breakthrough Therapy Designation
📊 SBS-IF Phase 2 data expected H1 2027
💰 Multi-billion-dollar GI & rare disease market opportunity
🤝 Potential pharma partnership/licensing deal
💊 Canalevia-CA1 potential full FDA approval
🐕 Neonorm Dog commercial growth
🔥 Multiple catalysts + strategic alternatives
🐂 Positive data + FDA progress + partnerships could unlock significant upside!
Multiple shots on goal!
#jagx #biotech #fda 🚀